Inventor · disambiguated record
Anthony J. Roecker
Also filed as: ROECKER ANTHONY · ROECKER ANTHONY J
24 granted patents·19 pending applications·181 citations·filing 2001–2023
94Inventor score
Files withMERCK SHARP & DOHME12MERCK SHARP & DOHME LLC8COLEMAN PAUL J7BERGMAN JEFFREY M4MERCER SWATI P3
Top patents by PatentIndex Score
43 records- 0196US8710076B22,5-disubstituted piperidine orexin receptor antagonistsBRESLIN MICHAEL J·Filed 2009·Granted Apr 29, 2014·38 cites·7 claims
- 0293US8362009B2Substituted diazepan orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2008·Granted Jan 29, 2013·28 cites·10 claims
- 0391US8349872B2Tripyridyl carboxamide orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2009·Granted Jan 8, 2013·21 cites·20 claims
- 0489US8703770B2Pyridazine carboxamide orexin receptor antagonistsCOLEMAN PAUL J·Filed 2009·Granted Apr 22, 2014·9 cites·14 claims
- 0589US8618102B2Bridged diazepan orexin receptor antagonistsCOLEMAN PAUL J·Filed 2007·Granted Dec 31, 2013·19 cites·12 claims
- 0688US8399494B22,5-disubstituted phenyl carboxamide orexin receptor antagonistsBERGMAN JEFFREY M·Filed 2009·Granted Mar 19, 2013·17 cites·15 claims
- 0787US7410998B2Inhibitors of NADH:ubiquinone oxidoreductaseSCRIPPS RESEARCH INST·Filed 2001·Granted Aug 12, 2008·23 cites·7 claims
- 0882US9732077B2Diazepane orexin receptor antagonistsKUDUK SCOTT D·Filed 2014·Granted Aug 15, 2017·3 cites·13 claims
- 0981US8030495B2Cyclopropyl pyrrolidine orexin receptor antagonistsCOLEMAN PAUL J·Filed 2008·Granted Oct 4, 2011·6 cites·21 claims
- 1079US8003797B2Pyridine carboxamide orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2008·Granted Aug 23, 2011·4 cites·16 claims
- 1173US8410142B2Bipyridine carboxamide orexin receptor antagonistsCOLEMAN PAUL J·Filed 2008·Granted Apr 2, 2013·2 cites·18 claims
- 1272US10519147B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Dec 31, 2019·1 cites·18 claims
- 1372US10221167B2Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·1 cites·46 claims
- 1472US8592457B2Isonicotinamide orexin receptor antagonistsBERGMAN JEFFREY M·Filed 2009·Granted Nov 26, 2013·3 cites·17 claims
- 1570US9586968B2Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2014·Granted Mar 7, 2017·2 cites·19 claims
- 1669US7652033B2HIF-1 inhibitorsUNIV EMORY·Filed 2004·Granted Jan 26, 2010·3 cites·2 claims
- 1766US2010087478A1HIF-1 InhibitorsVAN MEIR ERWIN G·Filed 2009·Application pending·0 cites
- 1864US2024228535A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1963US2025171467A1Fused pyrazole amide analogs as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2062US9273040B2Benzoxazolinone compounds with selective activity in voltage-gated sodium channelsLAYTON MARK E·Filed 2012·Granted Mar 1, 2016·1 cites·22 claims
- 2160US2025026762A1Fused pyrazole urea analogs as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2259US2005143449A1Non-steroidal farnesoid X receptor modulators and methods for the use thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2003·Application pending·0 cites
- 2359US2025223259A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2457US12492183B2Tetrahydroquinazoline derivatives as selective cytotoxic agentsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 9, 2025·0 cites·25 claims
- 2555US2024076291A1Modified isoindolinones as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2652US2023391758A1Modified benzofuran-carboxamides as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2751US2019233406A1HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELSMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2849US12427159B2Hydroxypyrrolidine-substituted arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME LLC·Filed 2020·Granted Sep 30, 2025·0 cites·15 claims
- 2947US12331022B2Spiropiperidine allosteric modulators of nicotinic acetylcholine receptorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 17, 2025·0 cites·5 claims
- 3046US10968210B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2017·Granted Apr 6, 2021·0 cites·19 claims
- 3146US2011195957A1Substituted diazepan orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2011·Application pending·0 cites
- 3245US2009088452A1Indole Orexin Receptor AntagonistsCOLEMAN PAUL J·Filed 2006·Application pending·0 cites
- 3343US2011301140A1Pyridine Carboxamide orexin Receptor AntagonistsBERGMAN JEFFREY M·Filed 2011·Application pending·0 cites
- 3442US2008045492A1Mitotic Kinesin InhibitorsCOLEMAN PAUL J·Filed 2005·Application pending·0 cites
- 3542US2009118200A1Proline bis-amide orexin receptor antagonistsBERGMAN JEFFREY M·Filed 2006·Application pending·0 cites
- 3641US2013210804A1Tricyclic mglur5 receptor modulatorsANTHONY NEVILLE J·Filed 2011·Application pending·0 cites
- 3740US10442778B2N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2017·Granted Oct 15, 2019·0 cites·18 claims
- 3840US9994570B2Bridged diazepane orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Jun 12, 2018·0 cites·12 claims
- 3936US9242995B2Isoxazolopyridine orexin receptor antagonistsLI DANSU·Filed 2012·Granted Jan 26, 2016·0 cites·12 claims
- 4036US2012196901A1Tertiary amide orexin receptor antagonistsCOLEMAN PAUL J·Filed 2010·Application pending·0 cites
- 4134US2012065205A1Pyrazine carboxamide orexin receptor antagonistsMERCER SWATI P·Filed 2010·Application pending·0 cites
- 4234US2012040998A12-alkyl piperidine mglur5 receptor modulatorsMERCER SWATI P·Filed 2010·Application pending·0 cites
- 4334US2012101106A1Tetrahydronapthyridine Orexin Receptor AntagonistsMERCER SWATI P·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anthony J. Roecker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →